Search

Your search keyword '"García, Héctor"' showing total 83 results

Search Constraints

Start Over You searched for: Author "García, Héctor" Remove constraint Author: "García, Héctor" Journal journal of the american college of cardiology Remove constraint Journal: journal of the american college of cardiology
83 results on '"García, Héctor"'

Search Results

3. Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Aortic Stenosis

5. Smoking Is Associated With Adverse Clinical Outcomes in Patients Undergoing Revascularization With PCI or CABG: The SYNTAX Trial at 5-Year Follow-Up

6. A Randomized Trial of a Dedicated Bifurcation Stent Versus Provisional Stenting in the Treatment of Coronary Bifurcation Lesions

7. Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis: 12-Month Clinical and Imaging Outcomes

8. 6-Month Clinical Outcomes Following Implantation of the Bioresorbable Everolimus-Eluting Vascular Scaffold in Vessels Smaller or Larger Than 2.5 mm

10. TCT-635 Performance of Near-Infrared Spectroscopy-Intravascular Ultrasound and Optical Coherence Tomography for Coronary Artery Plaque Structural Stress Analysis: Validation Against Histology

11. TCT-613 Comparison of Histology-Trained Deep Learning Approach With Human Expert Analysts for Automated Plaque Component Classification in Hybrid Intravascular Ultrasound-Optical Coherence Tomography Images

15. Longest Available Clinical Outcomes After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease: The DELFT (Drug Eluting stent for LeFT main) Registry

20. Distal Left Main Coronary Disease Is a Major Predictor of Outcome in Patients Undergoing Percutaneous Intervention in the Drug-Eluting Stent Era: An Integrated Clinical and Angiographic Analysis Based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) Registries

21. TCT-426 Electrocardiographically Gated Intravascular Image Segmentation Enables More Reproducible Volumetric Analysis of Atheroma Burden

28. TCT-89 Morphological Characteristics of Thin-Cap Fibroatheroma Lesions in Patients With and Without Future Adverse Events: Insights From the COMBINE (OCT-FFR) Study

29. TCT-82 Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events: Insights From the COMBINE FFR-OCT Trial

31. BALLOON-EXPANDABLE VALVE GEOMETRY AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH BICUSPID AORTIC STENOSIS

33. TCT-855 Optical coherence tomography appraisal of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing high versus low bivalirudin infusion. The MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT study

39. TCT-345 Optical coherence tomography appraisal of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion. The MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT study

40. TCT-352 Long-term Clinical Data and Multimodality Imaging Analysis of the BIOSOLVE-II Study with the Drug-eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries – BIOSOLVE-II

41. TCT-308 Comparison between fractional flow reserve (FFR) and Computational fractional flow reserve derived from three-dimensional intravascular ultrasound (FFR-IVUS), percentage of diameter stenosis by visual estimation and bi-dimensional quantitative coronary angiography.

42. COMPARISON OF CLINICAL OUTCOMES BETWEEN MAGMARIS (DREAMS 2G) AND ORSIRO DRUG ELUTING STENTS: POOLED PATIENT LEVEL ANALYSIS FROM BIOSOLVE II-III AND BIOFLOW II TRIALS

45. IMPACT OF PERIPROCEDURAL MYOCARDIAL BIOMARKER ELEVATION ON MORTALITY FOLLOWING PERCUTANEOUS CORONARY INTERVENTION: A POOLED PATIENT-LEVEL (N=13452) ANALYSIS OF CONTEMPORARY STENT TRIALS

48. TCT-573 Characterization of edge effects with second-generation drug-eluting absorbable metal scaffold assessed by optical coherence tomography, intravascular ultrasound grayscale, and virtual histology at 6- and 12-month. A Biosolve II substudy

Catalog

Books, media, physical & digital resources